Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq strategy to study Mycobacterium ulcerans adaptation within our original mouse model of spontaneous healing.

ABSTRACT: RNA-seq strategy to study Mycobacterium ulcerans adaptation within our original mouse model of spontaneous healing.

PROVIDER: PRJNA663495 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12642060.fastq.gz	Fastqsanger.gz
	SRR12642061.fastq.gz	Fastqsanger.gz
	SRR12642062.fastq.gz	Fastqsanger.gz
	SRR12642063.fastq.gz	Fastqsanger.gz
	SRR12642064.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

RNA-seq strategy to study Mycobacterium ulcerans adaptation within our original mouse model of spontaneous healing.

Project description:Mycobacterium ulcerans is the causal agent of Buruli ulcer, a chronic infectious disease and the third most common mycobacterial disease worldwide. Without early treatment, M. ulcerans provokes massive skin ulcers, caused by the mycolactone toxin, its main virulence factor. However, spontaneous healing may occur in Buruli ulcer patients several months or years after the disease onset. We have shown, in an original mouse model, that bacterial load remains high and viable in spontaneously healed tissues, suggesting that M. ulcerans switches to low levels of mycolactone production, adapting its strategy to survive in such a hostile environment. We investigated the regulation of mycolactone production, by using an RNA-seq strategy to study bacterial adaptation within our original mouse model of spontaneous healing. Pathway analysis and characterization of the tissue environment showed that the bacillus adapted to its new environment by modifying its metabolic activity and switching nutrient sources. Thus, M. ulcerans ensures its survival in healing tissues by reducing its secondary metabolism, leading to an inhibition of mycolactone synthesis and changes in cell wall composition. These findings shed new light on mycolactone regulation and pave the way for new therapeutic strategies.

2021-05-17 | GSE157956 | GEO

Fusobacterium ulcerans

Project description:Fusobacterium ulcerans overview

| PRJNA37617 | ENA

Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model.

Project description:Buruli Ulcer (BU) is a necrotizing skin disease caused by Mycobacterium ulcerans infection. BU is characterized by a wide range of clinical forms, including non-ulcerative cutaneous lesions that can evolve into severe ulcers if left untreated. Nevertheless, spontaneous healing has been reported to occur, although knowledge on this process is scarce both in naturally infected humans and experimental models of infection. Animal models are useful since they mimic different spectrums of human BU disease and have the potential to elucidate the pathogenic/protective pathway(s) involved in disease/healing. In this time-lapsed study, we characterized the guinea pig, an animal model of resistance to M. ulcerans, focusing on the macroscopic, microbiological and histological evolution throughout the entire experimental infectious process. Subcutaneous infection of guinea pigs with a virulent strain of M. ulcerans led to early localized swelling, which evolved into small well defined ulcers. These macroscopic observations correlated with the presence of necrosis, acute inflammatory infiltrate and an abundant bacterial load. By the end of the infectious process when ulcerative lesions healed, M. ulcerans viability decreased and the subcutaneous tissue organization returned to its normal state after a process of continuous healing characterized by tissue granulation and reepethelialization. In conclusion, we show that the experimental M. ulcerans infection of the guinea pig mimics the process of spontaneous healing described in BU patients, displaying the potential to uncover correlates of protection against BU, which can ultimately contribute to the development of new prophylactic and therapeutic strategies.

| S-EPMC4666642 | biostudies-literature

Corynebacterium ulcerans

Project description:Corynebacterium ulcerans Genome sequencing

| PRJNA273240 | ENA

Mycobacterium ulcerans

Project description:Mycobacterium ulcerans Genome sequencing

| PRJNA1008572 | ENA

Mycobacterium ulcerans

Project description:VNTR Profiling of M. ulcerans

| PRJNA812065 | ENA

Mycobacterium ulcerans

Project description:Mycobacterium ulcerans Raw sequence reads